Carisma Therapeutics, Inc. (CARM)

NASDAQ: CARM · Real-Time Price · USD

0.2360

+0.0066 (2.88%)

At close: Aug 22, 2025, 4:00 PM

0.2400

+0.0040 (1.69%)

After-hours: Aug 22, 2025, 7:31 PM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Chimeric Antigen Receptor Macrophage and Monocyte Cell Therapy	19.63M	Log In	Log In	Log In	Log In
Chimeric Antigen Receptor Macrophage and Monocyte Cell Therapy Growth	31.59%	Log In	Log In	Log In	Log In

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
United States	19.63M	Log In	Log In	Log In	Log In
United States Growth	31.59%	Log In	Log In	Log In	Log In